O'Dell Group, LLC Gamida Cell Ltd. Transaction History

O'Dell Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$0.25 - $1.02 $100 - $408	400 New	400 $0
Q2 2023 Aug 14, 2023	BUY	$0.73 - $2.37 $292 - $948	400 New	400 $0
Q3 2021 Nov 15, 2021	BUY	$3.85 - $6.44 $1,540 - $2,576	400 New	400 $2,000

11.4M

235K

70.5K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of O'Dell Group, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Dell Group, LLC with notifications on news.